Proteome Sciences (LON:PRM) Releases Earnings Results

Proteome Sciences (LON:PRM) announced its quarterly earnings data on Wednesday. The company reported GBX (0.41) EPS for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Price Performance

Shares of LON PRM opened at GBX 1.38 on Wednesday. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46. The business’s 50 day moving average price is GBX 1.72 and its two-hundred day moving average price is GBX 1.64. The company has a market cap of £4.82 million, a PE ratio of -1.32 and a beta of 0.16. Proteome Sciences has a twelve month low of GBX 1.11 and a twelve month high of GBX 4.40.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.